Stocks and Investing
Stocks and Investing
Wed, December 20, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, December 19, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jeffrey Hung Downgraded (VIGL) to Sell and Decreased Target to $4 on, Dec 19th, 2023
Jeffrey Hung of Morgan Stanley, Downgraded "Vigil Neuroscience, Inc." (VIGL) to Sell and Decreased Target from $13 to $4 on, Dec 19th, 2023.
Jeffrey has made no other calls on VIGL in the last 4 months.
There are 3 other peers that have a rating on VIGL. Out of the 3 peers that are also analyzing VIGL, 0 agree with Jeffrey's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jeffrey
- Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $23 on, Friday, November 17th, 2023
- Jason Butler of "JMP Securities" Initiated at Buy and Held Target at $23 on, Wednesday, October 18th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $24 on, Thursday, September 14th, 2023
Contributing Sources